光智科技(300489.SZ):公司研發的紅外車載AI系統於2024年已完成樣機開發和測試
格隆匯3月5日丨光智科技(300489.SZ)在投資者互動平臺表示,公司研發的紅外車載AI系統於2024年已完成樣機開發和測試,計劃於2025年進行小批量投產和路測,並推出更多型號的車載感知產品。公司將不斷拓寬紅外技術在車載物聯網等重要領域的應用,夜視系統藉助紅外技術,能夠在夜間或低能見度狀況下爲駕駛者提供清晰視野,有力保障駕駛安全。在智能駕駛系統里,紅外傳感器能對其他傳感器的功能加以補充,達成全天候監控,進而提升自動駕駛可靠性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.